Our News on Newswise

Newswise: DystoniaNetprocesspicture.png

New Artificial Intelligence Platform Uses Deep Learning to Diagnose Dystonia with High Accuracy in Less Than One Second

Researchers at Mass Eye and Ear have developed a unique diagnostic tool called DystoniaNet that uses artificial intelligence to detect dystonia from MRI scans in 0.36 seconds. DystoniaNet is the first technology of its kind to provide an objective...
28-Sep-2020 3:00 PM EDT Add to Favorites

Newswise: 6F4A3589_ArboledaPressReleasePortrait.jpg

Mass Eye and Ear Receives $4 Million Gift to Accelerate Research on Genetic Links to Alzheimer’s Disease Resistance

Mass Eye and Ear has received a five-year, $4 Million gift from Good Ventures to spur Dr. Joseph F. Arboleda-Velásquez's groundbreaking work into Alzheimer’s disease genetic resistance. This transformational gift will enable Dr....
15-Sep-2020 2:10 PM EDT Add to Favorites

Mass Eye and Ear Doctors Collaborate with Dana-Farber to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United States

Surgeons at Mass Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as “cultivated autologous limbal...
27-Aug-2020 1:25 PM EDT Add to Favorites

Newswise: DSC_0003-Liberman-C.jpg

Study uncovers hair cell loss as underlying cause of age-related hearing loss

In a new study of human ear tissues, hearing scientists have demonstrated that age-related hearing loss, also called presbycusis, is mainly caused by damage to hair cells, the sensory cells in the inner ear that transform sound-induced vibrations...
15-Jul-2020 12:10 PM EDT Add to Favorites

Newswise: EricPierceMDPhD2017.jpg

Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Massachusetts Eye and Ear, a member hospital of Mass General Brigham, is entering into an exclusive licensing agreement with Biogen to develop a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene, which are...
2-Jul-2020 8:00 AM EDT Add to Favorites

Multispecialty Centers that Treat Pediatric Swallowing Disorders Deliver Better Outcomes and Reduced Health Care Costs Compared to Traditional Specialist Visits

Children who choke when they drink or eat may have what’s known as dysphagia, or a swallowing disorder -- one of the most common medical complaints seen in young children. A new study has found that by combining different medical disciplines in...
15-Jun-2020 1:30 PM EDT Add to Favorites

Newswise: AEB_97134.jpg

Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project

The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham. AAVCOVID is a...
28-May-2020 8:00 AM EDT Add to Favorites

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

AveXis, will lead the manufacturing efforts of the new AAVCOVID vaccine, utilizing its cutting-edge AAV technology for treatment of rare and life-threatening neurological genetic diseases. AveXis has the option to manufacture the AAV vaccine for...
28-May-2020 8:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

The Massachusetts Eye and Ear is a specialty hospital dedicated to excellence in the care of disorders that affect the eye, ear, nose, throat, and adjacent regions of the head and neck. The Mass. Eye and Ear provides primary care and serves as a referral center for outpatient and inpatient medical and surgical care.

In conjunction with Harvard Medical School, Mass. Eye and Ear is committed to the education of future health care professionals, as well as the education of the public concerning the prevention, diagnosis, and treatment of the diseases in its specialties and concerning the rehabilitation of patients handicapped by these diseases.

Contacts

Leslie Dennis
Executive Assistant

Leslie_Dennis@meei.harvard.edu

617-573-3342

Erin Duggan
Senior Director of Communications and External Relations

Erin_Duggan@MEEI.HARVARD.EDU

617-573 3756

Amanda Gillespie

amanda_gillespie@meei.harvard.edu

617-398-2967

Ryan Jaslow
Senior Media Relations Manager
Health medicine

Ryan_Jaslow@meei.harvard.edu

617-573-4385

Twitter

close
0.38317